About 1 in 9 men will be diagnosed with prostate cancer during his lifetime, and prostate cancer is the second most common cancer in American men. For the 180,000 men diagnosed with prostate cancer each year, the diagnosis can be scary, confusing and uncertain, but there are many resources to help both patients and families deal not just with the diagnosis, but also with living with the disease and treatment. If you’ve been diagnosed with prostate cancer, your physician is the best person to guide your treatment and care.
Below are several resources that can provide useful information about prostate cancer and treatments.
American Cancer Society
Prostate Cancer Foundation
Cancer Support Community
His Prostate Cancer
Clinical trials are intended to help better understand innovative new medicines and are fundamental in ultimately delivering new treatments to patients in need. These clinical trials help determine whether a new treatment is safe and effective. We know the decision to participate in any clinical trial research is not made lightly, and we applaud all the patients and families who choose to take part. Your physician is the best person to help you decide if a clinical trial or any other treatment option is right for you.
Arvinas is currently conducting a Phase 1 clinical trial of ARV-110, an orally-bioavailable PROTAC® protein degrader designed to selectively target and degrade androgen receptor protein (AR). ARV-110 is being developed as a potential treatment for men with metastatic castration-resistant prostate cancer (mCRPC). The study will evaluate the safety and tolerability of ARV-110 in patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed on standard of care therapies. If you’re interested in learning more about this trial, please speak with your doctor and visit www.clinicaltrials.gov (Study ID NCT03888612).